The U.S. Food and Drug Administration recently issued its first-ever draft guidance on the use of AI for the development of drug and biological products. Entitled “Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations,” it serves as… Read More ›